Publication: Off-label use of ketamine for treatment-resistant depression in clinical practice: European perspective.
| dc.contributor.author | López-Díaz, Álvaro | |
| dc.contributor.author | Murillo-Izquierdo, Manuel | |
| dc.contributor.author | Moreno-Mellado, Elisa | |
| dc.date.accessioned | 2023-01-25T13:32:59Z | |
| dc.date.available | 2023-01-25T13:32:59Z | |
| dc.date.issued | 2019-04-29 | |
| dc.description.abstract | Ketamine therapy for treatment-resistant depression in European national health systems may only be considered after attempting all evidence-based antidepressant strategies outlined in clinical guidelines. This paper seeks to explain the ethical, regulatory and procedural framework for the off-label use of ketamine for treatment-resistant depression within a public healthcare system.Declaration of interestNone. | |
| dc.identifier.doi | 10.1192/bjp.2019.102 | |
| dc.identifier.essn | 1472-1465 | |
| dc.identifier.pmid | 31030677 | |
| dc.identifier.unpaywallURL | https://www.cambridge.org/core/services/aop-cambridge-core/content/view/7E343DF5A137842625DC6709CD011F39/S0007125019001028a.pdf/div-class-title-off-label-use-of-ketamine-for-treatment-resistant-depression-in-clinical-practice-european-perspective-div.pdf | |
| dc.identifier.uri | http://hdl.handle.net/10668/13886 | |
| dc.issue.number | 2 | |
| dc.journal.title | The British journal of psychiatry : the journal of mental science | |
| dc.journal.titleabbreviation | Br J Psychiatry | |
| dc.language.iso | en | |
| dc.organization | Fundación Pública Andaluza para la Gestión de la Investigación en Salud de Sevilla-FISEVI | |
| dc.organization | Hospital Universitario Virgen del Rocío | |
| dc.organization | Hospital Universitario Virgen Macarena | |
| dc.organization | Hospital Universitario Virgen Macarena | |
| dc.organization | Hospital Universitario Virgen Macarena | |
| dc.page.number | 447-448 | |
| dc.pubmedtype | Editorial | |
| dc.rights.accessRights | open access | |
| dc.subject | Treatment-resistant depression | |
| dc.subject | antidepressants | |
| dc.subject | ketamine | |
| dc.subject.mesh | Antidepressive Agents | |
| dc.subject.mesh | Depressive Disorder, Treatment-Resistant | |
| dc.subject.mesh | Europe | |
| dc.subject.mesh | Humans | |
| dc.subject.mesh | Ketamine | |
| dc.subject.mesh | Off-Label Use | |
| dc.subject.mesh | Practice Guidelines as Topic | |
| dc.subject.mesh | Safety | |
| dc.title | Off-label use of ketamine for treatment-resistant depression in clinical practice: European perspective. | |
| dc.type | research article | |
| dc.type.hasVersion | VoR | |
| dc.volume.number | 215 | |
| dspace.entity.type | Publication |